» Articles » PMID: 35867926

Hyperthyroidism in Children and Adolescents: Experience in a University Hospital in Colombia

Overview
Journal Biomedica
Specialty General Medicine
Date 2022 Jul 22
PMID 35867926
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Hyperthyroidism is a heterogeneous condition characterized by the excessive production of thyroid hormones. It represents a diagnostic and therapeutic challenge. Objective: To describe the clinical and paraclinical characteristics and the evolution and differences between the main etiologies in patients with hyperthyroidism treated by the Pediatric Endocrinology Service at the Hospital Universitario San Vicente Fundación in Medellín, Colombia, between July 1st., 2015, and June 30th., 2020. Materials and methods: We conducted a cross-sectional observational study with retrospective data collection. Results: We included 54 patients with a mean age of 11.9 years, 72.2% of whom were female; 85.2% had no history of comorbidities related to autoimmunity; 11.1% had a family history of Graves’ disease, and 29.6% of other thyroid diseases. Goiter was the most frequent clinical manifestation (83.3%) and 92.6% of the patients received treatment with methimazole, 79.6% required beta-blockers, and 11.2% additional drug therapy. Adverse drug reactions occurred in 16.7% of the patients and in 20.4% there was a resolution of hyperthyroidism (spontaneous: 9.3%; after radio-iodine ablation: 9.3%, and after surgery: 1.9%). Conclusion: Hyperthyroidism is a disease with diverse clinical manifestations. Its most frequent cause is Graves’ disease followed by hashitoxicosis, which in this study had a higher frequency than that reported in the literature. The duration and side effects of pharmacological treatment were similar to those previously reported, but the higher frequency of agranulocytosis is noteworthy.

Citing Articles

Real-world research on beta-blocker usage trends in China and safety exploration based on the FDA Adverse Event Reporting System (FAERS).

Yan Y, An W, Mei S, Zhu Q, Li C, Yang L BMC Pharmacol Toxicol. 2024; 25(1):86.

PMID: 39543745 PMC: 11566443. DOI: 10.1186/s40360-024-00815-w.

References
1.
Leger J, Oliver I, Rodrigue D, Lambert A, Coutant R . Graves' disease in children. Ann Endocrinol (Paris). 2018; 79(6):647-655. DOI: 10.1016/j.ando.2018.08.001. View

2.
Hanley P, Lord K, Bauer A . Thyroid Disorders in Children and Adolescents: A Review. JAMA Pediatr. 2016; 170(10):1008-1019. DOI: 10.1001/jamapediatrics.2016.0486. View

3.
Goldstein S, Katowitz W, Moshang T, Katowitz J . Pediatric thyroid-associated orbitopathy: the Children's Hospital of Philadelphia experience and literature review. Thyroid. 2008; 18(9):997-9. DOI: 10.1089/thy.2008.0014. View

4.
Perdomo C, Garcia-Goni M, Sancho L, Paricio J, Lozano M, De La Higuera M . Evaluation of the role of thyroid scintigraphy in the differential diagnosis of thyrotoxicosis. Clin Endocrinol (Oxf). 2020; 94(3):466-472. DOI: 10.1111/cen.14308. View

5.
Leger J, Carel J . Hyperthyroidism in childhood: causes, when and how to treat. J Clin Res Pediatr Endocrinol. 2012; 5 Suppl 1:50-6. PMC: 3608005. DOI: 10.4274/jcrpe.854. View